Immunology and Epidemiology of Infectious Diseases and Infection

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".

Deadline for manuscript submissions: 10 October 2024 | Viewed by 1821

Special Issue Editors


E-Mail Website
Guest Editor
Department of Epidemiology and Public Health, Sylhet Agricultural University, Sylhet, Bangladesh
Interests: infectious disease epidemiology and ecology

E-Mail Website
Guest Editor
1. Department of Microbiology & Immunology, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA
2. Department of Medicine, Sylhet Agricultural University, Sylhet, Bangladesh
Interests: immunology of infectious diseases; host-pathogen interaction; antiviral agents; antimicrobial resistance; vaccine; molecular epidemiology and zoonoses

Special Issue Information

Dear Colleagues,

The Special issue section “Immunology and Epidemiology of Infectious Diseases and infection” address an extended forum to advancing knowledge on the biological, immunological and epidemiological aspects of infections caused by pathogens; new insights into the mechanisms of infection; interactions of virulence factors with host cells; innate and adaptive immunity to infection; development of vaccines against pathogens that may lead to better diagnostic tools for prevention in epidemiology and Immunology of infectious diseases. This section combines original research articles and reviews on all aspects of infection in humans and animals. 

We sincerely welcome the scientific community contribution to the research on the infectious diseases immune system, epidemiology and its related infections.

Dr. Syed Sayeem Uddin Ahmed
Dr. Md Bashir Uddin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • innate and adaptive immunity
  • cytokines storm and inflammation
  • pathogenic mechanisms
  • vaccines and immunotherapies
  • diagnosis, prevention and control of infection and disease
  • epidemiology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1297 KiB  
Article
The Burden of Streptococcus pneumoniae-Related Admissions and In-Hospital Mortality: A Retrospective Observational Study between the Years 2015 and 2022 from a Southern Italian Province
by Fabrizio Cedrone, Vincenzo Montagna, Livio Del Duca, Laura Camplone, Riccardo Mazzocca, Federica Carfagnini, Valterio Fortunato and Giuseppe Di Martino
Vaccines 2023, 11(8), 1324; https://doi.org/10.3390/vaccines11081324 - 4 Aug 2023
Cited by 6 | Viewed by 1290
Abstract
Streptococcus pneumoniae (SP) has high worldwide incidence and related morbidity and mortality, particularly among children and geriatric patients. SP infection could manifest with pneumonia, bacteremia, sepsis, meningitis, and osteomyelitis. This was a retrospective study aimed at evaluating the incidence, comorbidities, and factors associated [...] Read more.
Streptococcus pneumoniae (SP) has high worldwide incidence and related morbidity and mortality, particularly among children and geriatric patients. SP infection could manifest with pneumonia, bacteremia, sepsis, meningitis, and osteomyelitis. This was a retrospective study aimed at evaluating the incidence, comorbidities, and factors associated with in-hospital mortality of pneumococcal disease-related hospitalization in a province in southern Italy from the years 2015 to 2022. This study was performed in the Local Health Authority (LHA) of Pescara. Data were collected from hospital discharge records (HDRs): this database is composed of 288,110 discharge records from LHA Pescara’s hospitals from 2015 to 2022. Streptococcus Pneumoniae-related hospitalizations were about 5% of the hospitalizations; 67% of these were without comorbidities; 21% were with one comorbidity; and 13% were with two or more comorbidities. Regarding mortality of SP infection, the most affected age group was older people, with the percentage of cases among the over-65s being more than 50% compared to the other age groups. HDRs represent a valid and useful epidemiological tool for evaluating the direct impact of pneumococcal disease on the population and also indirectly for evaluating the effectiveness of vaccination strategies and directing them. Full article
(This article belongs to the Special Issue Immunology and Epidemiology of Infectious Diseases and Infection)
Show Figures

Figure 1

Back to TopTop